OncLive is a web resource for physicians and other health professionals focused on the treatment of cancer. The source features peer-reviewed original medical journal articles, video interviews, panel discussions, major medical conference coverage, daily medical news and serves as the website for several oncology-focused magazines. All content in OncLive is free and does not require any registration.

Wikipedia
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

  • Dr. West on Lurbinectedin in SCLC
    H. Jack West, MD, a thoracic oncologist of Swedish Cancer Institute at Swedish Medical Center, discusses the emerging agent lurbinectedin in the small cell lung cancer (SCLC) landscape.
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

  • Biomarkers in Liver Cancer
    Arndt Vogel, MD, and Oliver Waidmann, MD, offer their perspectives on the use of prognostic and predictive biomarkers in liver cancer.
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

  • Immunotherapy in Liver Cancer
    Arndt Vogel, MD, and Oliver Waidmann, MD, discuss the potential for immunotherapy in liver cancer and review data from the CheckMate-040 clinical trial with nivolumab.
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

  • Future Directions for Liquid Biopsy in NSCLC
    Sandip Patel, MD, and Geoffrey R. Oxnard, MD, discuss the increasing acceptance of liquid biopsy approaches for diagnosis and treatment of resistance in patients with metastatic non–small cell lung cancer.
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

  • Liquid Biopsy and Next-Generation Sequencing
    Geoffrey R. Oxnard, MD, and Sandip Patel, MD, discuss the choices for genetic testing in metastatic non–small cell lung cancer and using the results of large panel testing to intervene on the patient’s behalf.
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

  • Upfront PD-L1 Blockade in Newly Diagnosed NSCLC
    Fred Hirsch, MD, PhD; Naiyer Rizvi, MD; and Everett Vokes, MD, discuss the paradigm shift associated with the introduction of frontline immunotherapy, including in combination with chemotherapy, in patients with metastatic non–small cell lung cancer without driver mutations.
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

  • Interpretation of NSCLC Plasma Genotyping Results
    Sandip Patel, MD, and Geoffrey R. Oxnard, MD, explains how to interpret the results of liquid biopsy results for metastatic non–small cell lung cancer and considerations for variants of unknown significance.
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

  • Dr. Garassino on the PACIFIC Trial for NSCLC
    Marina Chiara Garassino, MD, medical consultant in the Medical Oncology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, discusses the PACIFIC study for patients with non–small cell lung cancer (NSCLC).
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

  • Dr. Levine on Immunotherapy in Endometrial Cancer
    Douglas A. Levine, MD, professor, Department of Obstetrics and Gynecology, director, Division of Gynecologic Oncology, NYU Langone's Perlmutter Cancer Center, discusses immunotherapy for patients with endometrial cancer.
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

  • Dr. Martignetti on Next-Generation Sequencing in Fallopian Tube Cancer
    John A. Martignetti, MD, PhD, associate professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, network director for the Laboratory for Translational Research at the Western Connecticut Health Network, discusses next-generation sequencing for patients with fallopian tube cancer.
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

New YouTube videos detected.

Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video
Intellisphere Oncology Specialty Group
Intellisphere Oncology Specialty Group
YouTube Video

Out-Market Your Competitors?

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account Log in

By signing up, you agree to the Terms of Service and Privacy Policy.

Out-Market Your Competitors

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account

Already a user?  Log in

By signing up, you agree to the Terms of Service and Privacy Policy.